Immunotech Biopharm Ltd
HKEX:6978.HK
1.6 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 177.326 | 69.76 | 93.6 | 278.626 | 61.975 | 31.172 |
General & Administrative Expenses
| 53.223 | 97.708 | 104.254 | 106.208 | 36.829 | 11.647 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0.001 | 1.119 |
SG&A
| 53.223 | 97.708 | 104.254 | 106.208 | 36.829 | 11.647 |
Other Expenses
| 0 | 101.362 | 137.736 | -1.605 | 12.057 | 0.069 |
Operating Expenses
| 230.549 | 268.83 | 335.59 | 383.229 | 110.861 | 42.43 |
Operating Income
| -230.549 | -280.235 | -333.354 | -419.834 | -110.144 | -42.43 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -104.93 | -47.164 | -9.751 | -91.878 | -18.75 | 7.542 |
Income Before Tax
| -335.479 | -321.095 | -354.615 | -439.129 | -109.054 | -34.888 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | 31.739 | 20.87 | 19.213 | -1.343 | 8.677 |
Net Income
| -334.819 | -352.834 | -375.485 | -458.342 | -107.711 | -34.766 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.65 | -0.69 | -0.73 | -1.03 | -0.22 | -0.07 |
EPS Diluted
| -0.65 | -0.69 | -0.73 | -1.03 | -0.22 | -0.07 |
EBITDA
| -178.83 | -236.164 | -324.332 | -333.986 | -86.789 | -42.321 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |